Henric Bjarke
Tracked across 1 events · 12 articles · First seen Aug 20, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Lupin (company)'s wholly-owned subsidiary VISUfarma has entered into an exclusive licensing agreement with Visus Therapeutics Inc., a wholly-owned subsidiary of Tenpoint Therapeutics Holding Limited, to commercialize YUVEZZI, a once-daily eye drop for presbyopia, in the…
Impact: As CEO of Tenpoint, Henric Bjarke expressed enthusiasm for the partnership, emphasizing the fit with Lupin's commercial operations and VISUfarma's eyecare presence.
Aug 20, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Henric Bjarke live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard